Gut bacterial communities affect effectiveness of cancer drugs, predicting responses to next-generation treatments. Faecal microbiome transplantation can help non-responders, notes Laurence Zitvogel, study co-author from Gustave Roussy Cancer Campus.
Balance of gut microbial species impacts success of immune checkpoint inhibitors, reveals Fabio Grassi, immunologist. Research emphasizes the significance of gut bacteria in high-stakes cancer therapies like checkpoint inhibitors.
[
add
]
[
|
|
...
]